Related Experiment Video
Updated: Jul 3, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation
Ramiro París1, Ryan E Henry, Sarah J Stephens
1Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, Boulder, Colorado 80309-0347, USA.
Abstract:
The cellular response to Nutlin-3, a small-molecule inhibitor of the p53 repressor MDM2, varies widely among human cancer-derived cell types. Whereas HCT116 colorectal carcinoma cells display sustained cell cycle arrest, BV173 leukemia cells undergo rapid apoptosis and other cell lines show an intermediate response. We found that the expression of the p53 target genes p21, 14-3-3sigma and the microRNA miR-34a correlates tightly with the cell fate choice adopted. All three genes were strongly induced in arresting cells, but silenced in cells undergoing Nutlin-3-induced apoptosis. In contrast, key apoptotic p53 target genes were equally expressed in arresting and apoptotic cells. Interestingly, we establish that miR-34a cooperates with p21 and 14-3-3sigma to override the apoptotic signals generated by p53 activation. Strikingly, p53 binding to chromatin and p53-mediated recruitment of certain coactivators to all three target loci does not vary among cell types. Instead, the cell type-specific silencing of these genes is due to enhanced p21 mRNA degradation, 14-3-3sigma promoter DNA methylation and reduced processing of the miR-34a primary transcript. Thus, p53-independent events regulating expression of protein-coding genes and microRNAs within the network can define the cellular outcome of p53 activation.
Insights
Nutlin-3 treatment triggers varied cell fates in cancer, with p53 target gene expression differing. Cell type-specific mechanisms like mRNA degradation and DNA methylation control whether cells arrest or undergo apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The p53 tumor suppressor pathway is crucial for cancer treatment, but its activation by drugs like Nutlin-3 elicits diverse cellular responses.
- Nutlin-3 inhibits MDM2, leading to p53 stabilization and target gene activation, yet outcomes like cell cycle arrest or apoptosis vary across cancer cell types.
Purpose of the Study:
- To investigate the molecular mechanisms underlying differential cellular responses to Nutlin-3 treatment in human cancer cells.
- To identify key p53 target genes and regulatory pathways that dictate cell fate decisions (arrest vs. apoptosis) upon p53 activation.
Main Methods:
- Comparative analysis of gene expression (p21, 14-3-3sigma, miR-34a) in HCT116 and BV173 cells treated with Nutlin-3.
- Assessment of p53 binding to chromatin and coactivator recruitment across different cell types.
- Investigation of post-transcriptional and epigenetic regulatory mechanisms (mRNA degradation, DNA methylation, microRNA processing).
Main Results:
- Expression of p21, 14-3-3sigma, and miR-34a correlates with cell cycle arrest, while their silencing is observed in apoptotic cells.
- miR-34a, p21, and 14-3-3sigma cooperate to counteract p53-induced apoptosis.
- Cell type-specific gene silencing is mediated by enhanced p21 mRNA degradation, 14-3-3sigma promoter methylation, and reduced miR-34a processing, independent of p53 binding or coactivator recruitment.
Conclusions:
- p53-independent regulatory events governing p53 target genes and microRNAs determine the cellular outcome of p53 activation.
- Differential regulation of p21, 14-3-3sigma, and miR-34a expression is critical for cell fate decisions in response to Nutlin-3.
- Targeting these downstream regulatory mechanisms could offer novel therapeutic strategies in cancer treatment.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

